ALFA Finder
20:46 IST
BSE
Management Change
Parmax Pharma Management Change
Parmax Pharma's independent director Ami Shah resigned effective October 28, 2026. The exit follows a change in management and control of the company.
Parmax Pharma Ltd
- Share price
- ₹135.00
- Market cap
- ₹50.51 Cr
- Revenue (annual)
- ₹12.11 Cr
- Net profit (annual)
- ₹-4.16 Cr
- P/E (TTM)
- -42.3×Sector 43.8×
- Promoter holding
- 64.66%+33.86% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Capital Structure Change 5Management Change 3Other Announcement 2Annual General Meeting 2Promoter Selling (Off-Market) 1Promoter Reclassification 1Promoter Buying 1Open Offer 1Financial Results 1Board Meeting Date 1Adverse Business Impact 1
Time
3 announcements with these filters
20:46 IST
BSE
Management Change
Parmax Pharma Management Change
Parmax Pharma Ltd announced the resignation of Mr. Nikhil Uchat as an Independent Director of the Company, effective October 08, 2026.
22:10 IST
BSE
Management Change
Parmax Pharma Management Change
Parmax Pharma Limited announced the appointment of Dhiren Shah and Sunil Shah as Directors. Additionally, Ms. Salma Thobhani resigned as a Non-Executive Non-Independent Director.